Nirmatrelvir-ritonavir Therapy and COVID-19 Vaccination Improve Clinical Outcomes of SARS-CoV-2 Omicron Variant Infection
Description
To evaluate the effect of Nirmatrelvir-ritonavir therapy and COVID-19 vaccination on clinical outcomes of SARS-Cov-2 Omicron infection,we retrospectively analyzed the clinical data of 762 adult patients with confirmed Omicron BA2.2 variant infection
